NCT05865314 Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)
| NCT ID | NCT05865314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HEIDEGGER CP |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 164 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 164 participants in total. It began in 2023-05-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Due to medical advances and quality of care, mortality in adult intensive care units (ICUs) has decreased significantly in recent years, leading to a significant increase in the number of patients with high rehabilitation needs on discharge from the ICU. A specific management by a multidisciplinary team has been set up since 2017 at the Geneva-ICU for long-stay patients (hospitalised ≥ 7 days). This study aim to assess whether an optimization of the nutritional therapy coupled with an early mobility during and after the ICU stay allows an improvement in the muscle function at hospital discharge compared to patients receiving the standard care.
Eligibility Criteria
Inclusion Criteria: Any patient admitted to the adult ICU : * ≥18 years old * On mechanical ventilation with an expected length of stay ≥ 7 days * Requiring artificial nutrition (enteral and/or parenteral nutrition) Exclusion Criteria: Therapeutic withdrawal Pregnant or breastfeeding patients Neurological disorders with motor deficits: * New or pre-existing neuromuscular or nervous system disease * Spinal cord injury Severe polytrauma of the lower limbs (amputation etc.) Non-independent ambulation (including walking aids) before ICU admission For organizational reasons not allowing follow-up : * Transfer to another ICU * Patient living abroad from Switzerland * Patient living in nursing homes preceding to ICU admission * Incarcerated patients * Intellectual/cognitive disabilities or language barrier, limiting ability to follow the instructions
Contact & Investigator
Claudia Heidegger, MD
PRINCIPAL INVESTIGATOR
University Hospital, Geneva
Frequently Asked Questions
Who can join the NCT05865314 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05865314 currently recruiting?
Yes, NCT05865314 is actively recruiting participants. Contact the research team at claudia.heidegger@hcuge.ch for enrollment information.
Where is the NCT05865314 trial being conducted?
This trial is being conducted at Geneva, Switzerland.
Who is sponsoring the NCT05865314 clinical trial?
NCT05865314 is sponsored by HEIDEGGER CP. The principal investigator is Claudia Heidegger, MD at University Hospital, Geneva. The trial plans to enroll 164 participants.